0001415889-23-012570.txt : 20230823
0001415889-23-012570.hdr.sgml : 20230823
20230823170837
ACCESSION NUMBER: 0001415889-23-012570
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230822
FILED AS OF DATE: 20230823
DATE AS OF CHANGE: 20230823
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LaBarre Michael J.
CENTRAL INDEX KEY: 0001507174
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32335
FILM NUMBER: 231198293
MAIL ADDRESS:
STREET 1: 11388 SORRENTO VALLEY ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HALOZYME THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001159036
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 880488686
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12390 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 794-8889
MAIL ADDRESS:
STREET 1: 12390 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: HALOZYME THERAPEUTICS INC
DATE OF NAME CHANGE: 20040312
FORMER COMPANY:
FORMER CONFORMED NAME: GLOBAL YACHT SERVICES INC
DATE OF NAME CHANGE: 20010912
4
1
form4-08232023_090830.xml
X0508
4
2023-08-22
0001159036
HALOZYME THERAPEUTICS, INC.
HALO
0001507174
LaBarre Michael J.
C/O HALOZYME THERAPEUTICS, INC.
12390 EL CAMINO REAL
SAN DIEGO
CA
92130
false
true
false
false
SVP, CHIEF TECHNICAL OFFICER
1
Common Stock
2023-08-22
4
M
0
1925
18.41
A
153836
D
Common Stock
2023-08-22
4
S
0
1925
42.407
D
151911
D
Common Stock
2023-08-22
4
M
0
8075
19.98
A
159986
D
Common Stock
2023-08-22
4
S
0
8075
42.407
D
151911
D
Option to Purchase Common Stock
18.41
2023-08-22
4
M
0
1925
0
D
2028-02-14
Common Stock
1925
5580
D
Option to Purchase Common Stock
19.98
2023-08-22
4
M
0
8075
0
D
2030-02-10
Common Stock
8075
61099
D
The option exercises and sales reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.
Represents a weighted average sales price per share. These shares were sold at prices ranging from $42.15 to $42.735. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
This option was granted on February 14, 2018 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter.
This option was granted on February 10, 2020 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter.
/s/ James R. Oehler, Attorney-in-Fact
2023-08-23